<p>作者：Tomi Kilgore</p>
<p>據報道，特朗普正在考慮簽署一項行政命令，將大麻降級為第三類藥物，這可能為銀行服務打開大門。</p>
<p>在有關特朗普政府可能將大麻重新分類為一種遠不如現在危險的藥物的報道後，Tilray 的股票以及其他大麻公司的股票飆升，給投資者帶來了希望。</p>
<p>週五，Tilray Brands 的股票大幅上漲，市場對大麻終於有望被重新分類為低級別藥物的希望不斷上升，這可能為進一步合法化和銀行服務打開大門。</p>
<p>《華盛頓郵報》週四晚間報道，特朗普總統正在推動將大麻重新分類為第三類藥物，與一些處方藥如含可待因的泰諾或類固醇並列。目前，大麻被分類為第一類藥物，與海洛因和迷幻藥 LSD 同級。</p>
<p>CNBC 週五報道，特朗普可能在週一簽署行政命令，將大麻重新分類。</p>
<p>來自檔案（2024 年 9 月）：在共和黨候選人特朗普支持將大麻轉移到限制較少的類別後，大麻股票上漲。</p>
<p>這對 Tilray（TLRY）以及所有合法的大麻生產商和銷售商來説都是一個好消息，原因有很多。但最重要的可能是，這可能會促使大型銀行進入大麻業務，而他們一直避免這樣做，因為大麻在聯邦層面被歸類為非法，依據是《管制物質法》。</p>
<p>週五，Tilray 的股票上漲了 44.1%。交易量激增至超過 8000 萬股，而過去 30 天的日均交易量約為 510 萬股。</p>
<p>在大麻行業的其他公司中，加拿大大麻公司 Canopy Growth Corp.（CGC）（CA:WEED）的股票上漲了 54%，而 Cronos Group 的股票上漲了 14.7%。AdvisorShares Pure U.S. Cannabis ETF MSOS 飆升 54.3%，創下 13 個月來的新高。</p>
<p>缺乏銀行服務使得合法的大麻業務難以運營，因為缺乏資金以及處理大量現金所帶來的風險。</p>
<p>儘管旨在保護銀行在大麻合法的州內開展業務不受聯邦限制的《安全與公平執法監管法案》（SAFER）已在眾議院多次獲得通過，但在參議院尚未獲得投票。</p>
<p>特朗普的行政命令可能會改變這一切。</p>
<p>&#34;從更大的角度來看，這將是幾十年來最顯著的大麻改革，併為我們認為的多個額外催化劑奠定基礎，包括更多州合法化大麻、SAFER 銀行法案的通過，&#34;最終使接觸大麻的公司能夠將其股票上市到主要的美國證券交易所，Alliance Global Partners 的分析師 Aaron Grey 在給客户的報告中寫道。</p>
<p>他説，這也可能導致傳統消費品公司進行戰略投資。</p>
<p>請記住，《華盛頓郵報》的報道指出，白宮表示尚未做出任何決定，而大麻投資者之前曾遭受損失。</p>
<p>例如，Tilray 週五的股票上漲是自 9 月 29 日以來最大的一次。當天上漲了創紀錄的 60.9%，收於 18.50 美元，此前特朗普在他的社交媒體平台 Truth Social 上分享了一段視頻，宣傳了大麻植物中的一種化合物——大麻二酚在老年人護理中的好處。</p>
<p>週五，即使在大幅上漲後，Tilray 的股票仍比 9 月 29 日收盤時低 34.3%。</p>
<p>來自檔案（2025 年 2 月）：Trulieve、Curaleaf 和 Green Thumb 推出基於大麻的 THC 飲料，因大麻改革停滯不前。</p>
<p>-Tomi Kilgore</p>
<p>此內容由 MarketWatch 創作，MarketWatch 由道瓊斯公司運營。MarketWatch 與道瓊斯新聞通訊和《華爾街日報》獨立出版。</p>
<p>（完）道瓊斯新聞通訊</p>
<p>12-12-25 1722ET</p>

CRON

TLRY

<p>Tilray 的股票上漲了 44.1%，因為有報道稱特朗普總統可能會將大麻重新分類為第三類藥物，從而放寬銀行限制，並可能導致進一步的合法化。這一重新分類可能允許大型銀行與大麻企業進行交易，從而推動該行業的發展。其他大麻股票，如 Canopy Growth 和 Cronos Group，也出現了顯著的漲幅。然而，白宮尚未確認任何決定，過去投資者的樂觀情緒有時也顯得過於倉促</p>

<p>By Tomi Kilgore</p>
<div class="lb-trans"><p>作者：Tomi Kilgore</p>
</div><p>Trump is reportedly mulling an executive order to downgrade marijuana to a Schedule III drug, which could open the door to banking services</p>
<div class="lb-trans"><p>據報道，特朗普正在考慮簽署一項行政命令，將大麻降級為第三類藥物，這可能為銀行服務打開大門。</p>
</div><p>Tilray's stock, and shares of other cannabis companies, soared after reports gave investors hope that the Trump administration would move to have marijuana reclassified as a much less dangerous drug than it is now.</p>
<div class="lb-trans"><p>在有關特朗普政府可能將大麻重新分類為一種遠不如現在危險的藥物的報道後，Tilray 的股票以及其他大麻公司的股票飆升，給投資者帶來了希望。</p>
</div><p>Shares of Tilray Brands rocketed Friday amid rising hope that cannabis is finally on the doorstep of being rescheduled as a lower-class drug, which could open doors for further legalization and banking services.</p>
<div class="lb-trans"><p>週五，Tilray Brands 的股票大幅上漲，市場對大麻終於有望被重新分類為低級別藥物的希望不斷上升，這可能為進一步合法化和銀行服務打開大門。</p>
</div><p>The Washington Post reported late Thursday that President Donald Trump was pushing to reclassify marijuana as a Schedule III drug alongside some prescription drugs like Tylenol with codeine or anabolic steroids. It is currently classified as a Schedule I drug, on par with heroin and lysergic acid diethylamide, or LSD.</p>
<div class="lb-trans"><p>《華盛頓郵報》週四晚間報道，特朗普總統正在推動將大麻重新分類為第三類藥物，與一些處方藥如含可待因的泰諾或類固醇並列。目前，大麻被分類為第一類藥物，與海洛因和迷幻藥 LSD 同級。</p>
</div><p>CNBC reported Friday that Trump could sign an executive order to reschedule marijuana as soon as Monday.</p>
<div class="lb-trans"><p>CNBC 週五報道，特朗普可能在週一簽署行政命令，將大麻重新分類。</p>
</div><p>From the archives (September 2024): Cannabis stocks rally after Republican candidate Trump supports moving drug to less restrictive category</p>
<div class="lb-trans"><p>來自檔案（2024 年 9 月）：在共和黨候選人特朗普支持將大麻轉移到限制較少的類別後，大麻股票上漲。</p>
</div><p>That would be a boon for Tilray (TLRY), and for all legal cannabis producers and sellers, for a few reasons. But probably the most important is that it would likely lead to larger banks to get into the weed businesses, something they've avoided because cannabis was federally classified as illegal under the Controlled Substance Act.</p>
<div class="lb-trans"><p>這對 Tilray（TLRY）以及所有合法的大麻生產商和銷售商來説都是一個好消息，原因有很多。但最重要的可能是，這可能會促使大型銀行進入大麻業務，而他們一直避免這樣做，因為大麻在聯邦層面被歸類為非法，依據是《管制物質法》。</p>
</div><p>Tilray's stock soared 44.1% on Friday. Trading volume ballooned to well above 80 million shares, compared with the full-day average over the past 30 days of about 5.1 million shares.</p>
<div class="lb-trans"><p>週五，Tilray 的股票上漲了 44.1%。交易量激增至超過 8000 萬股，而過去 30 天的日均交易量約為 510 萬股。</p>
</div><p>Among others in the weed business, shares of Canopy Growth Corp. (CGC) (CA:WEED) shot up 54%, and Cronos Group's stock ran up 14.7%. The AdvisorShares Pure U.S. Cannabis ETF MSOS skyrocketed 54.3% to a 13-month high.</p>
<div class="lb-trans"><p>在大麻行業的其他公司中，加拿大大麻公司 Canopy Growth Corp.（CGC）（CA:WEED）的股票上漲了 54%，而 Cronos Group 的股票上漲了 14.7%。AdvisorShares Pure U.S. Cannabis ETF MSOS 飆升 54.3%，創下 13 個月來的新高。</p>
</div><p>The lack of banking options has made it difficult to run a legal cannabis business given the lack of funding and the dangers associated with dealing in piles of cash.</p>
<div class="lb-trans"><p>缺乏銀行服務使得合法的大麻業務難以運營，因為缺乏資金以及處理大量現金所帶來的風險。</p>
</div><p>And while the Secure and Fair Enforcement Regulation, or SAFER, banking act, aimed at protecting banks from federal restrictions when doing business in a state where cannabis was legal, has been approved by the House of Representatives multiple times, it has yet to get a vote in the Senate.</p>
<div class="lb-trans"><p>儘管旨在保護銀行在大麻合法的州內開展業務不受聯邦限制的《安全與公平執法監管法案》（SAFER）已在眾議院多次獲得通過，但在參議院尚未獲得投票。</p>
</div><p>An executive order from Trump could change all that.</p>
<div class="lb-trans"><p>特朗普的行政命令可能會改變這一切。</p>
</div><p>&#34;Bigger picture, this would be the most notable cannabis reform in decades and set the stage for a number of additional catalysts in our view, including additional states legalizing cannabis, SAFER banking being passed,&#34; and ultimately having plant-touching cannabis companies move the listing of their stocks to major U.S. stock exchanges, Alliance Global Partners analyst Aaron Grey wrote in a note to clients.</p>
<div class="lb-trans"><p>&#34;從更大的角度來看，這將是幾十年來最顯著的大麻改革，併為我們認為的多個額外催化劑奠定基礎，包括更多州合法化大麻、SAFER 銀行法案的通過，&#34;最終使接觸大麻的公司能夠將其股票上市到主要的美國證券交易所，Alliance Global Partners 的分析師 Aaron Grey 在給客户的報告中寫道。</p>
</div><p>He said it could also lead to strategic investments from companies in traditional consumer-facing businesses.</p>
<div class="lb-trans"><p>他説，這也可能導致傳統消費品公司進行戰略投資。</p>
</div><p>Keep in mind that the Washington Post story noted that the White House said no decision has yet been made, and that cannabis investors have been burned before.</p>
<div class="lb-trans"><p>請記住，《華盛頓郵報》的報道指出，白宮表示尚未做出任何決定，而大麻投資者之前曾遭受損失。</p>
</div><p>For example, Tilray's stock rally Friday was the biggest since Sept. 29. It had gained a record 60.9% that day, to close at $18.50, after Trump shared a video on his social-media platform Truth Social, which touted the benefits of cannabidiol - a compound from the cannabis plant - in the care of seniors.</p>
<div class="lb-trans"><p>例如，Tilray 週五的股票上漲是自 9 月 29 日以來最大的一次。當天上漲了創紀錄的 60.9%，收於 18.50 美元，此前特朗普在他的社交媒體平台 Truth Social 上分享了一段視頻，宣傳了大麻植物中的一種化合物——大麻二酚在老年人護理中的好處。</p>
</div><p>On Friday, even after the big run-up, Tilray's stock ended the trading week 34.3% below where it closed on Sept. 29.</p>
<div class="lb-trans"><p>週五，即使在大幅上漲後，Tilray 的股票仍比 9 月 29 日收盤時低 34.3%。</p>
</div><p>From the archives (February 2025): Trulieve, Curaleaf and Green Thumb launch hemp-based THC drinks as cannabis reforms stall</p>
<div class="lb-trans"><p>來自檔案（2025 年 2 月）：Trulieve、Curaleaf 和 Green Thumb 推出基於大麻的 THC 飲料，因大麻改革停滯不前。</p>
</div><p>-Tomi Kilgore</p>
<div class="lb-trans"><p>-Tomi Kilgore</p>
</div><p>This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.</p>
<div class="lb-trans"><p>此內容由 MarketWatch 創作，MarketWatch 由道瓊斯公司運營。MarketWatch 與道瓊斯新聞通訊和《華爾街日報》獨立出版。</p>
</div><p>(END) Dow Jones Newswires</p>
<div class="lb-trans"><p>（完）道瓊斯新聞通訊</p>
</div><p>12-12-25 1722ET</p>
<div class="lb-trans"><p>12-12-25 1722ET</p>
</div>

Tilray's stock takes off on hope that cannabis will soon be seen as more like steroids than heroin

Tilray 的股票因市場希望大麻將很快被視為更類似於類固醇而非海洛因而大幅上漲